Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Zantac Recall: Sanofi Heeds To Potential Ranitidine Contaminant

Oct 18 2019

• By Malcolm Spicer

FDABldg64Lab_1200x675

Related Content

Testing Ranitidine With Too Much Heat Could Generate NDMA, FDA Says

Oct 02 2019

EMA Tells Firms To Evaluate OTCs For Carcinogenic Nitrosamines

Sep 27 2019

CVS, Walgreen Suspend OTC Ranitidine Sales As FDA Investigates Contamination

Sep 30 2019

Related Companies

Sanofi

Additional Topics

International Europe Canada United States OTC Drugs Recalls FDA Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Distribution Drug Safety Manufacturing Regulation Policy Safety Cancer Consumer

More from International

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window